Skip to content

Clinical trials

Terminated Phase 2 Purpura, Thrombocytopenic, Idiopathic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Phase: Phase 2 Status: Terminated Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20102
20211
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shionogi2
Assistance Publique - Hôpitaux de Paris1
National Heart, Lung, and Blood Institute (NHLBI)1
Novartis Pharmaceuticals1
Pfizer1
Veralox Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic7
Thrombocytopenia3
Blood Platelet Disorders2
Hematologic Diseases2
Purpura, Thrombotic Thrombocytopenic2
Anemia, Hemolytic, Autoimmune1
Bronchiolitis Obliterans Syndrome1
Graft vs Host Disease1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.